Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I didn't think of that. Originally, I bought WYE as a complement to ELN as they are partners in development of AD drugs. I do see that no pharma or biotech I own was up for the day. Perhaps next week...........
As one playing along at home who happens to own both WYE and RPRX, that would be quite a pleasant scenario.
FRPT provided a nice exit AH for the shares I bought today at 14.30. However - that was pure luck since I had NOT realized that earnings were being reported AH. I'm an idiot!
From my POV only, your post makes PowerPlay an unreliable PHGI poster at best.
Regards, Cat
The precipitous drop in this stock along with the shenanigans in the rest of the market drove me precariously close to a margin call in one account. I hadn't thought I was even close to being over leveraged. If any others were in the same boat - I can really understand taking a bit of profit here - (I didn't, but I sure thought about it)
Regards,
Cat
Nice! They update that daily. I added small bit (250) at 16.50 also.
jmrsage1 That's a good method of keeping up with the news. I do as many searches as I have time for, but it seems like it's never enough. (Maybe I'm too diversified)
jmrsage1-Thank you. I had not seen this.
Watching FRPT - cannot find any news.
115,000 @ .2031 16.07
We're being very quiet, we don't want to scare it.
And here I always thought it was good to purchase your assets as cheaply as possible and then see how much you can make them appreciate in value.
Buy Sheep-Sell Deer!
Oh for heaven's sake! WTH do you think this says? And I think every PR put out by every company says basically the same thing. There's a whole lot more of it too. Give it up Avdave, those of us who are actual investors know what we're dealing with.
We do not undertake and specifically decline any obligation to publicly release the result of any revisions that may be made to any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
Avdave, I guess you live in Utopia, where everything goes exactly as planned, everyday, there are no problems, or unexpected occurrences and no one ever has to make the slightest change in his or her plans.
Unfortunately for the rest of us, including those involved in PHGI, we live in the real world where things can and do change necessitating that we make adjustments as we go along.
Would it be possible for you to actually contribute something instead of asking what amounts to really clueless, repetitious question and FUD?
As you have stated often, you're not a shareholder, I doubt you're a shareholder of any company, but that is clearly just my opinion.
I do not understand your problem here. What was said on 7/31 clearly updates and supersedes what was said on 6/26.
jerry - I believe Betancourtwill make fewer errors as time goes on. Vizquel always seemed perfectly focused and I think Yuni has not mastered this as yet.
Avdave, Can you not read or are you just trying to cause more FUD?
You say:
"Did he not say there was a record date, ex-dividend date and a payment date (all of which have passed by the way) for some dividend of shares of a Canadian subsidiary?"
What was actually said as of the 7/31 PR was
What is the actual Ex-Dividend date?
In a previous Press Release, management announced an ex-dividend date of July 3, 2007. Due to compliance requirements management has amended that date forward, contingent upon formal CNQ approval. Management intends to announce a new formal ex-dividend date in compliance with all applicable regulations at such time.
What is it about the above statement that you do not understand or do not believe?
Remember - no innuendo - simply facts.
OT Baseball Well, well, someone who follows (and goes to) the same games I do. I am not, however, a huge a-rod fan. I wouldn't trade either Yuni or Beltre to get him back. I actually thought Vizquel was a better SS in the field, though not at the plate. It seemed Yuni was determined that we were not going to extra innings last night. <g>
This board is supposed to refer to PHGI matters, I'm sure there's a board somewhere that discusses typos in depth on a daily basis. Please go find it and and introduce yourself.
Here you discuss the facts - not innuendo - of PHGI.
CUZ - an extremely tradable REIT. It's been killed of late due to the subprime woes, but it's totally unaffected in reality. The fundies are excellent and it works a little differently than most REITS. When their assets reach a certain point of profitability - they are sold and the money returned to shareholders in form of special dividend. Doesn't happen every year, but often enough. It has big swings most everyday - 25.65-26.95 today. (Sorry - no chart)
Have a good weekend all.
Cat
Pretty sure you are correct.
I think she should amble back towards $20-$21 now.
Approved by FDA for Crohn's in August 1998. Just recently approved for pediatric Crohn's by EU -June of 07.
Oh yes, I'm aware. It was meant tongue in cheek. I don't believe that following ML is any kind of DD at all. But then - WTHDIK?
Cat
Dew, You seem to be rather focused on the ML report. Is that because it reflects your own views?
Listening to the AC yesterday, it became evident just how miserable a disease Crohn's really is. The current therapies are not good enough. Those who testified in favor of Tysabri - where either they or a relative or friend had been in the trials - stressed over and over again how much the QoL improved while they were able to take the infusions.
I expect Ty will be approved with restrictions. Those who testified made it very clear that they were more than willing to take whatever risk exists to improve their lives. The Dr's. also stressed that this group as a whole is aware of the risks, but when they fail other therapies,and surgery is the court of last resort - the prognosis becomes dim, indeed.
I really don't care what ML thinks of Ty - actually I don't care what any analyst thinks of any stock. I decide for myself whether or not to invest - based on my DD.
Somehow, I had the idea that you did the same.
Regards,
Cat
ML has never thought much of Tysabri, even for MS. As you're no doubt aware CEO Kelly Martin left ML to go to ELN -
Erika Whittaker trashes them any chance she gets.
Before the FDA voted to bring Ty back Merrill Lynch analyst Erica Whittaker, a long-term bear on Elan’s stock, is refusing to lift her “sell” recommendation, for the moment at least. She said the share price reaction after the decision reflects “an over-optimistic view that Tysabri sales could exceed $2 billion, which we continue to believe is highly unlikely.” Her peak forecast, is a more modest $500m by 2010
Ty's ramp may be slower than first thought, but I do believe it will surpass ML's expectations by a good bit. And- ELN is still her top sell for 2007!
It is hardly a surprise to find that they think little of it for Crohns as well.
That's quite a good question. I'm not trying to avoid giving figures, but there is not enough info in yet. The EMEA, as you're aware, did not approve, and where it's quite possible that they will at some point, there is nothing there. Today's panel was quite conflicted about restrictions, with the Chairman actually wanting less - however, Joyce Korvick, the FDA's director of the gastroenterology division, said the agency likely would allow the drug to be used in certain Crohn's patients but under tightly controlled circumstances. Does that mean they will give a limited approval? Who knows.
The bottom line for the PPS - I expect not much - no matter the approval. If you ask me again after I know what label we get, I'll be glad to make an estimate on sales.
Regards,
Cat
ELN - AC on Tysabri for Crohns approved with restrictions -12 yes, 3 no, 1 abstention
It's kind of amazing how many posters on this PHGI board are willing to spend a lot of time asking questions and generally trying to cast aspersions on the mgmt in one form or other, but are apparently unwilling to take the same amount of time to make a simple phone call or two to get an answer.
Personally, I find the board has become to restrictive - there are no peripheral discussions being allowed - which to me cuts off a lot of possible exchanges of information.
However the board belongs to PQL and Dudette and they can run it as they see fit.
I remain a long, strong shareholder and I wish all the others of the same persuasion the best of luck.
Someone please send me a PM if this board ever stops being run like we've been sent to detention.
Best to you!
Cat
ELN update If you bought in early today and have a nice profit - you might consider taking some off of the table. Tomorrow is the AC for Crohns. There is no guarantee that the panel will approve although they should. ELN has also been know to go down on good news - it happens regularly. We *could* do this all over again tomorrow.
Although the majority of my shares are invested - I do have trading shares which as I bought every .50 down -and I am selling every .50 up - just in case.
Disclosure - I am an elanoholic and my advice must be taken with 2 ibuprofin and an infusion of Tysabri!
Regards,
Cat
Lampman, Please take your request PM - this is the PHGI board.
Oh gee - another brand new alias. How lucky for us. Tell us lampman - do you own any PHGI?
On ELN -Let me clarify something here on the ELN AC. ELN and BIIB worked with the FDA to position TY so that it could be approved for Crohns. That is to say they are requesting approval with a label of *last try before surgery". In that context, there is no reason that the AC should not approve it as the current therapies have no better safety record. However - the AC panel has not the most favorable make-up - as noted.
(I also added shares this morning)
Regards,
Cat
Are we to assume that you have made a serious attempt to answer these questions for yourself?
After all, I do DD for myself - I'm not quite sure why I should do it for you too.
Yes. This is the Alabama Dept. of Revenue. I assume you to find that sufficiently independent.
http://www.ador.state.al.us/motorfuels/licenseddist.html (home Page)Motor Fuels
Publication of Licensed Distributors
Contains the Gasoline, Aviation and Motor Fuels Licensees, and the Lubricating Oil Permit Holders
G" Indicates a gasoline license. Holders of this license may purchase and sell tax-free gasoline, motor fuel, aviation fuels, and blendstock product
http://www.ador.state.al.us/motorfuels/dist.pdf go to page 3.
This should be satisfactory.
Further - to agree to transport x number of gallons of bio-fuel per year without having a tanker fleet and a license would be quite a poor way to do do business.
Perhaps you could find another board to ask your questions on - one where you actually own some stock - if indeed there is such a one.
Did it occur to you to actually do a bit of DD and see if, in fact, there was an independent source which could verify the PR?
No? Did to me and I found one quite easily. I can only assume that you would rather cause FUD.
I have it in 4 accounts - 2 Scottrade and 2 Fido - I hope ALL of them can sort it correctly.
nope. I'm saying you can't come up with anything that proves what you say.
BTW - I CAN prove that Crew is a licensed and Bonded petroleum dealer in AL.
Yes, I said I could read for myself what else they do deliver. You are the one disputing that they deliver petroleum - it is up to you to provide the link that makes the PHGI PR false and misleading.
OK - This is what the PR says:
About Crew Distributing Co., Inc.:
Crew Distributing, Co., Inc. is a Chevron/ Texaco distributor, and has for over 30 years distributed petroleum fuels to portions of Alabama, Georgia and Florida in the Southeastern United States.
Where is the link that says they DO NOT distribute petroleum fuels. I can read what else they DO distribute - I want to know where it says what they DON'T distribute.
Tia.